產(chǎn)品詳情
簡單介紹：
Anti-ANKRD13B抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-ANKRD13B抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-ANKRD13B
Cat. Number:
Anti-ANKRD13B抗體KL-9745R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Ankyrins are membrane adaptor molecules that play important roles in coupling integral membrane proteins to the spectrin-based cytoskeleton network. Mutations of ankyrin genes can lead to severe genetic diseases,Anti-ANKRD13B抗體 such as fatal cardiac arrhythmias and hereditary spherocytosis. ANKRD13B (ankyrin repeat domain 13B) is a 626 amino acid protein that contains two ANK repeats and three ubiquitin-interacting motif (UIM) repeats. Conserved in dog, cow, mouse and rat, ANKRD13B exists as two alternatively spliced isoforms. The gene that encodes ANKRD13B maps to human chromosome 17, which makes up over 2.5% of the human genome, with about 81 million bases encoding over 1,200 genes. Two key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. BRCA1 is recognized as a genetic determinant of early onset breast cancer. Chromosome 17 is also linked to neurofibromatosis, dysregulated Schwann cell growth, Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease.
Also known as:
Ankrd13b; Anti-ANKRD13B抗體ANKRD13B(ankyrin repeat domain 13B); ankyrin repeat domain 13B; AN13B_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ANKRD13B.
●
Predicted Molecular Weight: 70kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 Anti-ANKRD13B抗體ELISA=1:500-1000 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working dilutions mustAnti-ANKRD13B抗體 be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-ANKRD13B抗體 be determined by the end user.
kl070Hu01 過氧蛋白同源物(PXDN)多克隆抗體 Polyclonal Antibody to Peroxidasin Homolog (PXDN)
kl131Hu01 抵抗素樣蛋白β(RETNLβ)多克隆抗體 Polyclonal Antibody to Resistin Like Beta (RETNLb)
kl171Hu01 R-脊椎蛋白1(RSPO1)多克隆抗體 Polyclonal Antibody to R-Spondin 1 (RSPO1)
kl171Mu01 R-脊椎蛋白1(RSPO1)多克隆抗體 Polyclonal Antibody to R-Spondin 1 (RSPO1)
kl173Hu01 R-脊椎蛋白3(RSPO3)多克隆抗體 Polyclonal Antibody to R-Spondin 3 (RSPO3)
kl195Hu01 分泌跨膜蛋白1(SECTM1)多克隆抗體 Polyclonal Antibody to Secreted And Transmembrane Protein 1 (SECTM1)
kl264Hu01 特異性蛋白1(Sp1)多克隆抗體 Polyclonal Antibody to Specificity Protein 1 (Sp1)
kl267Hu01 SklC樣蛋白1(SklCL1)多克隆抗體 Polyclonal Antibody to SklC Like Protein 1 (SklCL1)
kl267Ra01 SklC樣蛋白1(SklCL1)多克隆抗體 Polyclonal Antibody to SklC Like Protein 1 (SklCL1)
kl277Hu01 睪素2(TIC2)多克隆抗體 Polyclonal Antibody to Testican 2 (TIC2)
kl286Mu01 類固醇5α還原酶1(SRD5α1)多克隆抗體 Polyclonal Antibody to Steroid 5 Alpha Reductase 1 (SRD5a1)
kl286Ra01 類固醇5α還原酶1(SRD5α1)多克隆抗體 Polyclonal Antibody to Steroid 5 Alpha Reductase 1 (SRD5a1)
kl347Hu01 T-細胞**調(diào)節(jié)因子1(TCIRG1)多克隆抗體 Polyclonal Antibody to T-Cell, Immune Regulator 1 (TCIRG1)
kl373Hu01 Tolloid樣蛋白1(TLL1)多克隆抗體 Polyclonal Antibody to Tolloid Like Protein 1 (TLL1)
kl405Mu01 腫瘤壞死因子α誘導(dǎo)蛋白6(TNFαIP6)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 6 (TNFaIP6)
kl410Hu01 雙解絲蛋白1(TWF1)多克隆抗體 Polyclonal Antibody to Twinfilin 1 (TWF1)
kl427Ra01 Ras相關(guān)C3肉毒菌**底物1(Rac1)多克隆抗體 Polyclonal Antibody to Ras Related C3 Botulinum Toxin Substrate 1 (Rac1)
